These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2502875)

  • 1. [Secondary multiple resistance during treatment of tuberculosis].
    Hansen M; Evald T
    Ugeskr Laeger; 1989 Apr; 151(16):1002-3. PubMed ID: 2502875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Resistance of Mycobacterium tuberculosis in Ferrol, Spain. Associated factors].
    García Rodríguez JF; Mariño Callejo A; Lorenzo García MV; Rodríguez Mayo M; Domínguez Gómez D; Sesma Sánchez P
    Med Clin (Barc); 1999 Nov; 113(15):572-4. PubMed ID: 10605682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes and patterns of drug resistance of mycobacterium tuberculosis in patients with pulmonary tuberculosis (by data of the microbiological laboratory of research production association "Phthysiology")].
    Gorokhova TV
    Probl Tuberk; 1997; (2):33-5. PubMed ID: 9235582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of pulmonary tuberculosis patients with primary drug resistant Mycobacterium tuberculosis].
    Protopopova NM; Bessonova GS; Cherednichenko LP
    Probl Tuberk; 1987; (1):27-30. PubMed ID: 3104897
    [No Abstract]   [Full Text] [Related]  

  • 6. [Resistance problems in Mycobacteria tuberculosis and the treatment of severe tuberculosis with secondary antitubercular agents].
    Vojtek J; Holecková R; Rozánek R; Starosta V; Strnad M; Sebests J; Strusa V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1965; 8(5):589-92. PubMed ID: 4955225
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
    Khomenko AG; Chukanov VI; Korneev AA
    Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-resistant tuberculosis: resistance mechanisms and rapid susceptibility testing.
    Pfyffer GE
    Schweiz Med Wochenschr; 2000 Dec; 130(49):1909-13. PubMed ID: 11153397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Shorter treatment of pulmonary tuberculosis is only acceptable with at least 4 drugs in the initial combination of tuberculostatic agents].
    Veen J
    Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2164-7. PubMed ID: 8984351
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug resistant tuberculosis in Estonia.
    Kruuner A; Sillastu H; Danilovitsh M; Levina K; Svenson SB; Källenius G; Hoffner SE
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):130-3. PubMed ID: 9562123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of tuberculosis for the 1980's.
    Dutt AK; Stead WW
    Clin Chest Med; 1980 May; 1(2):243-52. PubMed ID: 6794977
    [No Abstract]   [Full Text] [Related]  

  • 14. The modern treatment of pulmonary tuberculosis.
    Costello J
    Postgrad Med J; 1983; 59 Suppl 3():181-4. PubMed ID: 6417637
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study on relapse cases of pulmonary tuberculosis].
    Takikawa S
    Kekkaku; 2009 Dec; 84(12):769-72. PubMed ID: 20491146
    [No Abstract]   [Full Text] [Related]  

  • 16. DOTS and drug resistance: a silver lining to a darkening cloud.
    Chaisson RE; Coberly JS; De Cock KM
    Int J Tuberc Lung Dis; 1999 Jan; 3(1):1-3. PubMed ID: 10094162
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
    [No Abstract]   [Full Text] [Related]  

  • 18. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [2 cases of drug-resistant pulmonary tuberculosis treated with ofloxacin].
    Krasucka-Kluźniak A; Krakówka P
    Pneumonol Pol; 1989 Apr; 57(4):249-52. PubMed ID: 2516906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.
    Cox HS; Niemann S; Ismailov G; Doshetov D; Orozco JD; Blok L; Rüsch-Gerdes S; Kebede Y
    Clin Infect Dis; 2007 Jun; 44(11):1421-7. PubMed ID: 17479936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.